Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2022
Sensient Technologies Corporation (NYSE: SXT) announced its first quarter 2022 results, reporting consolidated revenue of $355.5 million, a slight decline from $359.7 million in the same period last year. Operating income rose to $52.8 million, compared to $46.9 million in Q1 2021, and diluted earnings per share increased from 75 cents to 88 cents. Despite foreign currency headwinds impacting revenue by 2%, the company raised its full-year guidance for diluted earnings per share and revenue growth based on strong performance and favorable pricing adjustments.
- Operating income increased to $52.8 million, up 12.6% year-over-year.
- Diluted earnings per share rose to 88 cents, a 17.3% increase compared to last year.
- Color Group revenue increased by 9.4%, showing strong demand in Food & Pharmaceutical Colors and Personal Care.
- Adjusted local currency revenue increased by 8.4% in Q1.
- Raised 2022 full-year GAAP diluted earnings per share guidance to high-teen growth rate.
- Consolidated revenue decreased by 1.2% compared to the previous year.
- Flavors & Extracts Group revenue fell by 9.1%, attributed to divestiture effects.
- Foreign currency translation reduced revenue and earnings per share by approximately 2% and 4% respectively.
- Corporate & Other operating costs slightly increased by 1.4%.
Sensient Raises 2022 Guidance Based on Strong First Quarter Results and Favorable Outlook
The 2021 first quarter reported results include divestiture & other related costs and operational improvement plan costs, which in total decreased 2021 first quarter diluted earnings per share by
BUSINESS REVIEW |
||||
Reported |
||||
Revenue | Quarter |
|||
Flavors & Extracts |
- |
|||
Color |
|
|||
|
||||
Total Revenue |
- |
|||
|
||||
Adjusted |
||||
Local Currency (1) |
||||
Revenue | Quarter |
|||
Flavors & Extracts |
|
|||
Color |
|
|||
|
||||
Total Revenue |
|
|||
(1) Adjusted local currency percentage changes are described in more detail in the "Reconciliation of Non-GAAP Amounts" at the end of this release. |
Corporate & Other reported operating costs of
2022 OUTLOOK
The Company now expects 2022 revenue to grow at a mid-to-high single-digit rate in local currency compared to the Company’s 2021 adjusted revenue(2). The Company’s previous 2022 revenue guidance was for a mid-single-digit growth rate in local currency. The Company now expects 2022 adjusted EBITDA(2) and diluted earnings per share to grow at a high single- to double-digit rate in local currency compared to the Company’s 2021 adjusted EBITDA(2) and the Company’s 2021 adjusted diluted earnings per share(2) of
The Company now expects earnings per share reported on a
The Company’s guidance is based upon current trends, current tax law, and the effects of COVID-19 to date. The full impacts of the ongoing COVID-19 pandemic remain uncertain and management will continue to monitor its impacts on our business.
(2) |
See “Reconciliation of Non-GAAP Amounts” at the end of this release for more information. |
USE OF NON-GAAP FINANCIAL MEASURES
The Company’s non-GAAP financial measures eliminate the impact of certain items, which, depending on the measure, include, currency movements, depreciation and amortization, non-cash share-based compensation, divestiture & other related costs, operational improvement plan costs and income, and the results of the divested operations. These measures are provided to enhance the overall understanding of the Company’s performance when viewed together with the GAAP results. Refer to “Reconciliation of Non-GAAP Amounts” at the end of this release.
CONFERENCE CALL
The Company will host a conference call to discuss its 2022 first quarter financial results at
A replay of the call will be available one hour after the end of the conference call through
This release contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws including under “2022 Outlook” above. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the impact and uncertainty created by the ongoing COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, the availability and cost of raw materials, energy, and other supplies, the availability and cost of labor, logistics, and transportation; the uncertain impacts of the ongoing conflict between
ABOUT
(In thousands, except percentages and per share amounts) | |||||||||||
(Unaudited) | |||||||||||
Consolidated Statements of Earnings | Three Months Ended |
||||||||||
2022 |
2021 |
% Change |
|||||||||
Revenue | $ |
355,521 |
|
$ |
359,702 |
|
(1.2 |
%) |
|||
Cost of products sold |
|
230,675 |
|
|
244,089 |
|
(5.5 |
%) |
|||
Selling and administrative expenses |
|
72,057 |
|
|
68,716 |
|
4.9 |
% |
|||
Operating income |
|
52,789 |
|
|
46,897 |
|
12.6 |
% |
|||
Interest expense |
|
2,993 |
|
|
3,433 |
|
|||||
Earnings before income taxes |
|
49,796 |
|
|
43,464 |
|
|||||
Income taxes |
|
12,725 |
|
|
11,796 |
|
|||||
Net earnings | $ |
37,071 |
|
$ |
31,668 |
|
17.1 |
% |
|||
Earnings per share of common stock: | |||||||||||
Basic | $ |
0.89 |
|
$ |
0.75 |
|
|||||
Diluted | $ |
0.88 |
|
$ |
0.75 |
|
|||||
Average common shares outstanding: | |||||||||||
Basic |
|
41,865 |
|
|
42,263 |
|
|||||
Diluted |
|
42,148 |
|
|
42,389 |
|
|||||
Results by Segment | Three Months Ended |
||||||||||
Revenue |
2022 |
2021 |
|
% Change | |||||||
Flavors & Extracts | $ |
182,727 |
|
$ |
200,911 |
|
(9.1 |
%) |
|||
Color |
|
148,438 |
|
|
135,720 |
|
9.4 |
% |
|||
|
36,465 |
|
|
33,840 |
|
7.8 |
% |
||||
Intersegment elimination |
|
(12,109 |
) |
|
(10,769 |
) |
|||||
Consolidated | $ |
355,521 |
|
$ |
359,702 |
|
(1.2 |
%) |
|||
Operating Income | |||||||||||
Flavors & Extracts | $ |
27,579 |
|
$ |
27,018 |
|
2.1 |
% |
|||
Color |
|
30,657 |
|
|
26,594 |
|
15.3 |
% |
|||
|
8,204 |
|
|
6,752 |
|
21.5 |
% |
||||
Corporate & Other |
|
(13,651 |
) |
|
(13,467 |
) |
|||||
Consolidated | $ |
52,789 |
|
$ |
46,897 |
|
12.6 |
% |
(In thousands) | ||||||||
(Unaudited) | ||||||||
Consolidated Condensed Balance Sheets | ||||||||
2022 |
2021 |
|||||||
Cash and cash equivalents | $ |
32,175 |
|
$ |
25,740 |
|
||
Trade accounts receivable |
|
282,265 |
|
|
261,121 |
|
||
Inventories |
|
422,837 |
|
|
411,635 |
|
||
Prepaid expenses and other current assets |
|
46,081 |
|
|
42,657 |
|
||
Total Current Assets |
|
783,358 |
|
|
741,153 |
|
||
|
429,814 |
|
|
435,009 |
|
|||
Property, plant, and equipment (net) |
|
445,251 |
|
|
446,478 |
|
||
Other assets |
|
130,196 |
|
|
122,853 |
|
||
Total Assets | $ |
1,788,619 |
|
$ |
1,745,493 |
|
||
Trade accounts payable | $ |
114,858 |
|
$ |
125,519 |
|
||
Short-term borrowings |
|
7,475 |
|
|
8,539 |
|
||
Other current liabilities |
|
92,050 |
|
|
98,247 |
|
||
Total Current Liabilities |
|
214,383 |
|
|
232,305 |
|
||
Long-term debt |
|
530,005 |
|
|
503,006 |
|
||
Accrued employee and retiree benefits |
|
28,441 |
|
|
28,579 |
|
||
Other liabilities |
|
54,080 |
|
|
43,178 |
|
||
Shareholders' Equity |
|
961,710 |
|
|
938,425 |
|
||
Total Liabilities and Shareholders' Equity | $ |
1,788,619 |
$ |
1,745,493 |
(In thousands, except per share amounts) | ||||||||
(Unaudited) | ||||||||
Consolidated Statements of Cash Flows | ||||||||
Three Months Ended |
||||||||
2022 |
2021 |
|||||||
Cash flows from operating activities: | ||||||||
Net earnings | $ |
37,071 |
|
$ |
31,668 |
|
||
Adjustments to arrive at net cash (used in) provided by operating activities: | ||||||||
Depreciation and amortization |
|
13,056 |
|
|
12,799 |
|
||
Share-based compensation expense |
|
4,163 |
|
|
2,113 |
|
||
Net (gain) loss on assets |
|
(48 |
) |
|
161 |
|
||
Loss on divestitures and other charges |
|
- |
|
|
1,238 |
|
||
Deferred income taxes |
|
4,211 |
|
|
4,257 |
|
||
Changes in operating assets and liabilities: | ||||||||
Trade accounts receivable |
|
(20,841 |
) |
|
(27,237 |
) |
||
Inventories |
|
(11,901 |
) |
|
27,621 |
|
||
Prepaid expenses and other assets |
|
(11,111 |
) |
|
(13,239 |
) |
||
Trade accounts payable and other accrued expenses |
|
(10,267 |
) |
|
(6,242 |
) |
||
Accrued salaries, wages, and withholdings from employees |
|
(12,425 |
) |
|
(10,872 |
) |
||
Income taxes |
|
7,063 |
|
|
5,742 |
|
||
Other liabilities |
|
137 |
|
|
955 |
|
||
Net cash (used in) provided by operating activities |
|
(892 |
) |
|
28,964 |
|
||
Cash flows from investing activities: | ||||||||
Acquisition of property, plant, and equipment |
|
(12,736 |
) |
|
(14,244 |
) |
||
Proceeds from sale of assets |
|
89 |
|
|
69 |
|
||
Proceeds from divestiture of businesses |
|
- |
|
|
4,059 |
|
||
Other investing activities |
|
434 |
|
|
286 |
|
||
Net cash used in investing activities |
|
(12,213 |
) |
|
(9,830 |
) |
||
Cash flows from financing activities: | ||||||||
Proceeds from additional borrowings |
|
40,099 |
|
|
21,530 |
|
||
Debt payments |
|
(6,275 |
) |
|
(8,999 |
) |
||
Purchase of treasury stock |
|
- |
|
|
(11,665 |
) |
||
Dividends paid |
|
(17,211 |
) |
|
(16,535 |
) |
||
Other financing activities |
|
(1,679 |
) |
|
(228 |
) |
||
Net cash provided by (used in) financing activities |
|
14,934 |
|
|
(15,897 |
) |
||
Effect of exchange rate changes on cash and cash equivalents |
|
4,606 |
|
|
(7 |
) |
||
Net increase in cash and cash equivalents |
|
6,435 |
|
|
3,230 |
|
||
Cash and cash equivalents at beginning of period |
|
25,740 |
|
|
24,770 |
|
||
Cash and cash equivalents at end of period | $ |
32,175 |
|
$ |
28,000 |
|
||
Supplemental Information | ||||||||
Three Months Ended |
2022 |
2021 |
||||||
Dividends paid per share | $ |
0.41 |
|
$ |
0.39 |
|
(In thousands, except percentages and per share amounts) | |||||||||||
(Unaudited) | |||||||||||
Reconciliation of Non-GAAP Amounts | |||||||||||
The Company's results for the three months ended |
|||||||||||
Three Months Ended |
|||||||||||
2022 |
2021 |
% Change | |||||||||
Revenue (GAAP) | $ |
355,521 |
|
$ |
359,702 |
|
(1.2 |
%) |
|||
Revenue of the divested product lines |
|
- |
|
|
(25,570 |
) |
|||||
Adjusted revenue | $ |
355,521 |
|
$ |
334,132 |
|
6.4 |
% |
|||
Operating income (GAAP) | $ |
52,789 |
|
$ |
46,897 |
|
12.6 |
% |
|||
Divestiture & other related costs – Cost of products sold |
|
- |
|
|
25 |
|
|||||
Divestiture & other related costs – Selling and administrative expenses |
|
- |
|
|
1,547 |
|
|||||
Operating income of the divested product lines |
|
- |
|
|
(2,927 |
) |
|||||
Operational improvement plan - Selling and administrative expenses |
|
- |
|
|
1,001 |
|
|||||
Adjusted operating income | $ |
52,789 |
|
$ |
46,543 |
|
13.4 |
% |
|||
Net earnings (GAAP) | $ |
37,071 |
|
$ |
31,668 |
|
17.1 |
% |
|||
Divestiture & other related costs, before tax |
|
- |
|
|
1,572 |
|
|||||
Tax impact of divestiture & other related costs |
|
- |
|
|
793 |
|
|||||
Net earnings of the divested product lines, before tax |
|
- |
|
|
(2,927 |
) |
|||||
Tax impact of the divested product lines |
|
- |
|
|
723 |
|
|||||
Operational improvement plan costs, before tax |
|
- |
|
|
1,001 |
|
|||||
Tax impact of operational improvement plan |
|
- |
|
|
(296 |
) |
|||||
Adjusted net earnings | $ |
37,071 |
|
$ |
32,534 |
|
13.9 |
% |
|||
Diluted earnings per share (GAAP) | $ |
0.88 |
|
$ |
0.75 |
|
17.3 |
% |
|||
Divestiture & other related costs, net of tax |
|
- |
|
|
0.06 |
|
|||||
Results of operations of the divested product lines, net of tax |
|
- |
|
|
(0.05 |
) |
|||||
Operational improvement plan costs, net of tax |
|
- |
|
|
0.02 |
|
|||||
Adjusted diluted earnings per share | $ |
0.88 |
$ |
0.77 |
|
14.3 |
% |
||||
Note: Earnings per share calculations may not foot due to rounding differences. |
(In thousands) | ||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||
Reconciliation of Non-GAAP Amounts - Continued | ||||||||||||||||||||||||
Results by Segment | Three Months Ended |
|||||||||||||||||||||||
Revenue |
2022 |
|
Adjustments (1) |
|
Adjusted
|
|
2021 |
|
Adjustments (1) |
|
Adjusted
|
|||||||||||||
Flavors & Extracts | $ |
182,727 |
|
$ |
- |
|
$ |
182,727 |
|
$ |
200,911 |
|
$ |
(24,889 |
) |
$ |
176,022 |
|
||||||
Color |
|
148,438 |
|
|
- |
|
|
148,438 |
|
|
135,720 |
|
|
(536 |
) |
|
135,184 |
|
||||||
|
36,465 |
|
|
- |
|
|
36,465 |
|
|
33,840 |
|
|
(295 |
) |
|
33,545 |
|
|||||||
Intersegment elimination |
|
(12,109 |
) |
|
- |
|
|
(12,109 |
) |
|
(10,769 |
) |
|
150 |
|
|
(10,619 |
) |
||||||
Consolidated | $ |
355,521 |
|
$ |
- |
|
$ |
355,521 |
|
$ |
359,702 |
|
$ |
(25,570 |
) |
$ |
334,132 |
|
||||||
Operating Income | ||||||||||||||||||||||||
Flavors & Extracts | $ |
27,579 |
|
$ |
- |
|
$ |
27,579 |
|
$ |
27,018 |
|
$ |
(2,880 |
) |
$ |
24,138 |
|
||||||
Color |
|
30,657 |
|
|
- |
|
|
30,657 |
|
|
26,594 |
|
|
40 |
|
|
26,634 |
|
||||||
|
8,204 |
|
|
- |
|
|
8,204 |
|
|
6,752 |
|
|
(87 |
) |
|
6,665 |
|
|||||||
Corporate & Other |
|
(13,651 |
) |
|
- |
|
|
(13,651 |
) |
|
(13,467 |
) |
|
2,573 |
|
|
(10,894 |
) |
||||||
Consolidated | $ |
52,789 |
|
$ |
- |
$ |
52,789 |
|
$ |
46,897 |
|
$ |
(354 |
) |
$ |
46,543 |
|
|||||||
(1) For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, adjustments consist of the results of the divested product lines, divestiture & other related costs, and operational improvement plan costs. |
(In thousands, except percentages) | ||||||||
(Unaudited) | ||||||||
Reconciliation of Non-GAAP Amounts - Continued | ||||||||
The following tables summarize the percentage change in the 2022 results compared to the 2021 results for the corresponding periods. | ||||||||
Three Months Ended |
||||||||
Revenue | Total | Foreign Exchange Rates |
Adjustments (2) | Adjusted Local Currency |
||||
Flavors & Extracts |
( |
|
( |
|
( |
|
|
|
Color |
|
|
( |
|
( |
|
|
|
|
|
( |
|
( |
|
|
||
Total Revenue |
( |
|
( |
|
( |
|
|
|
|
|
|
|
|
|
|
||
Operating Income |
|
|
|
|
|
|
|
|
Flavors & Extracts |
|
|
( |
|
( |
|
|
|
Color |
|
|
( |
|
|
|
|
|
|
|
( |
|
( |
|
|
||
Corporate & Other |
|
|
|
|
( |
|
|
|
Total Operating Income |
|
|
( |
|
( |
|
|
|
Diluted Earnings Per Share |
|
|
( |
|
|
|
|
|
Adjusted EBITDA |
|
|
( |
|
N/A |
|
|
|
(2) For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, Diluted Earnings per Share, and Adjusted EBITDA, adjustments consist of the results of the divested product lines, divestiture & other related costs, and operational improvement plan costs. |
The following table summarizes the reconciliation between Operating Income (GAAP) and Adjusted EBITDA for the three months ended |
|||||||||||
Three Months Ended |
|||||||||||
2022 |
2021 |
% Change |
|||||||||
Operating income (GAAP) | $ |
52,789 |
|
$ |
46,897 |
|
|
||||
Depreciation and amortization |
|
13,056 |
|
|
12,799 |
|
|||||
Depreciation and amortization, divested product lines |
|
- |
|
|
(49 |
) |
|||||
Share-based compensation expense |
|
4,163 |
|
|
2,113 |
|
|||||
Divestiture & other related costs, before tax |
|
- |
|
|
1,572 |
|
|||||
Results of operations of the divested product lines, before tax |
|
- |
|
|
(2,927 |
) |
|||||
Operational improvement plan costs, before tax |
|
- |
|
|
1,001 |
|
|||||
Adjusted EBITDA | $ |
70,008 |
|
$ |
61,406 |
|
|
||||
The following table summarizes the reconciliation between Net cash provided by operating activities (GAAP) and Free Cash Flow for the three months ended |
|||||||||||
Three Months Ended |
|||||||||||
2022 |
2021 |
% Change |
|||||||||
Net cash (used in) provided by operating activities (GAAP) | $ |
(892 |
) |
$ |
28,964 |
|
( |
||||
Capital expenditures |
|
(12,736 |
) |
|
(14,244 |
) |
|||||
Free Cash Flow | $ |
(13,628 |
) |
$ |
14,720 |
|
( |
||||
We have included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable period-over-period performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this release and our |
Category: Earnings
View source version on businesswire.com: https://www.businesswire.com/news/home/20220428005822/en/
(414) 347-3706
Source:
FAQ
What were Sensient Technologies' first quarter 2022 earnings per share (EPS)?
How did Sensient Technologies' revenue in Q1 2022 compare to Q1 2021?
What is Sensient's revenue growth outlook for 2022?
What impact did foreign currency translation have on Sensient's Q1 2022 results?